ETFMG Treatments Testing & Adv ETF (GERM)

$16.84 0.37 (2.25%)

13:45 EDT GERM Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 92,620

PE Ratio -

EPS -

Volume (Avg. Vol.) 1,269

Day's Range $16.62 - $16.86

52-Week Range $15.67 - $21.70

Dividend & Yield $0.16 (0.95%)

GERM Stock Predictions, Articles, and ETFMG Treatments Testing & Adv ETF News

From the Web

Biotech ETFs rally in Q4 fueled by 73.6% surge in Moderna's stock price (NASDAQ:MRNA)

From Seeking Alpha Dec 22, 2022

Exchange traded funds tied to biotech sector gained momentum during Q4, led by a larger-than-70% surge in vaccine maker Moderna's (MRNA) share price since early October.

Biotech ETFs That Outperformed Last Week

From Talk Markets Dec 20, 2021

Though the broad U.S. market saw a tumultuous ride last week with most of the sectors in red, biotechnology was the biggest gainer.

5 Best Sector ETFs of November

From Talk Markets Dec 1, 2021

Though the broad markets ended the month in red, a few sector ETFs performed remarkably well.

ETFs to Buy on Most-Bullish Wall Street Outlook in Two Decades

From Talk Markets Aug 16, 2021

Investors seeking to tap the most bullish view could consider the following ETFs. These funds are showing solid strength this year and will likely continue their momentum going forward.

Tuesday Talk: Summer Stock

From Talk Markets Jul 6, 2021

Summer is in full swing and as Q2 ends and its earning season begins it is time to take stock of 1H 2021 and see where things may be heading in 2H.

Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates

From Talk Markets Jul 4, 2021

The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.

ADVERTISEMENT